Lifecore (LFCR) Biomedical announced that it has appointed Thomas Guldager as vice president, operations. An experienced pharmaceutical industry professional with extensive contract development and manufacturing organization, CDMO, expertise, Guldager is highly regarded for his strong operations and finance background, which Lifecore believes will help him drive operational productivity within the company’s performance-driven culture. In conjunction with this appointment, Jackie Klecker has been named executive vice president, quality and development services, a newly created position which will take advantage of her leadership and strong regulatory compliance experience to maintain the company’s reputation for excellence in this area.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFCR:
- Lifecore reports Q1 EPS (53c) vs. (35c) last year
- Lifecore reiterates FY25 revenue view $126.5M – $130M, consensus $127.56M
- Morning Movers: ZIM Integrated drops as dockworkers agree to end strike
- Jobs data surprise to upside: Morning Buzz
- Lifecore Biomedical Raises $24.3M, Expands Capacity and Clientele